News Sentiment

SMMT sentiment intelligence

Summit Therapeutics Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 55 Balanced news tone 17 relevant articles
Exchange MEX Mexico
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 290.12 Week of 17 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

86/100 classification confidence.

Company focus 17

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +0.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Summit Therapeutics schedules July 23 update on operations

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 86/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 0.0% over four weeks
Fair value -22.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 13
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 17
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 7
Stock Titan 3
Business Wire 2
DirectorsTalk Interviews 1
The AI Journal 1
PR Newswire 1
Bloomberg.com 1
BioSpace 1

Event Lens

What the news is about

Classified themes
Market update 13
Earnings 2
Analyst action 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-17 of 17